Adebrelimab Injection: Clinical Trials

13 trials of Adebrelimab Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting, 4 not yet recruiting, 1 active not recruiting. 13 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Recruiting 8, Not yet recruiting 4, Active not recruiting 1
Phase 15Recruiting 5

Follow Adebrelimab Injection: new trials by email Literature Review of Adebrelimab Injection trials Research Report on Adebrelimab Injection

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations
HS-20093 for Injection, Adebrelimab Injection - Non-Small Cell Lung Cancer
Phase 2RecruitingHansoh BioMedical R&D Company762026-10-082026-10-23
Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Adebrelimab Injection, Dalpiciclib Isethionate, Cisplatin - HNSCC
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital322026-09-012026-08-21
A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma
SHR-8068 Injection, Adebrelimab Injection, Apatinib Mesylate Tablets - Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk
Phase 2Not yet recruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.1202026-07-012026-07-02
Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Adebrelimab Injection - Esophageal Squamous Cell Carcinoma (ESCC)
Phase 2RecruitingSun Yat-sen University422026-06-172026-06-10
Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD
Adebrelimab Injection, Apatinib Mesylate Tablets - Small Cell Lung Carcinoma
Phase 2Not yet recruitingPeking University Cancer Hospital & Institute442026-01-312026-01-22
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Adebrelimab Injection, SHR-A1811 for Injection, SHR-A1904 for Injection - Gastric Cancer, Gastroesophageal-junction Cancer
Phase 2RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.2002025-08-282026-01-09
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
SHR-8068 Injection, Adebrelimab Injection, Bevacizumab Injection - Colorectal Cancer
Phase 2Active not recruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.1032025-07-222026-08-11
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
SHR-A1811, Carboplatin, Bevacizumab - Ovarian Cancer
Phase 1 / Phase 2RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.1502025-03-182026-09-11
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
SHR-1826, SHR-4642, SHR-9839 - Advanced Solid Tumors
Phase 1 / Phase 2RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.8762025-02-182025-12-03
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
SHR-A2102, Adebrelimab injection, SHR-8068 injection - Advanced Urothelial Carcinoma
Phase 1 / Phase 2RecruitingShanghai Hengrui Pharmaceutical Co., Ltd.902024-11-042024-11-18
Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer
Adebrelimab injection, Albumin-Bound Paclitaxel, Carboplatin injection - Resectable Esophageal Squamous Cell Carcinoma
Phase 2Not yet recruitingShanghai Zhongshan Hospital422024-10-012024-09-19
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
Adebrelimab - Gastric Cancer
Phase 1 / Phase 2RecruitingCancer Hospital Chinese Academy of Medical Science, Shenzhen Center522024-08-032025-01-15
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
SHR-A2102 for Injection, Adebrelimab Injection, Cisplatin injection - Advanced or Metastatic Non-small Cell Lung Cancer
Phase 1 / Phase 2RecruitingShanghai Hengrui Pharmaceutical Co., Ltd.2482024-07-302025-12-23

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Stomach Neoplasms (2)  ·  Colorectal Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Ovarian Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd. (5)  ·  Shanghai Hengrui Pharmaceutical Co., Ltd. (2)  ·  Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center (1)  ·  Hansoh BioMedical R&D Company (1)  ·  Peking University Cancer Hospital & Institute (1)  ·  Shanghai Zhongshan Hospital (1)  ·  Sun Yat-sen University (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)

Countries

China (11)

Top investigators

Jun Zhao (1)